Benzocaine Topical Products: Sprays, Gels and Liquids – Risk of Methemoglobinemia
Audience: Family Practice, Pharmacy, Consumers ISSUE: FDA notified healthcare professionals and patients that FDA continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, associated with benzocaine products…
Related posts:
- American Regent Injectable Products: Recall – Visible Particulates in Products Audience: Pharmacy Bacteriostatic Sodium Chloride Injection, USP, 0.9%, 30 mL...
- Unapproved Cough, Cold, Allergy Products: FDA Prompts Removal From Market Audience: Consumer, Family Practice, Pharmacy ISSUE: FDA announced that it...




facebook
rss
twitter